Cocrystal Pharma Inc (NASDAQ:COCP) Gains Momentum: Up Or Down?

Clinical stage biotech company Cocrystal Pharma Inc (NASDAQ:COCP) has emerged as one of the notable gainers over the course of the past month, having gained 14% during the period.

Yesterday, the Cocrystal stock came into sharp focus after the company announced that its COVID 19 protease inhibiting product CDI 45205 is active against the virus and also against two well known variants. The antiviral activity of the product was evaluated by an independent laboratory. It should be noted that new variants of the COVID 19 virus have wreaked havoc in many nations.

The interim Chief Executive Officer and President of the company Sam Lee spoke about the latest findings. Lee said that the company is considerably encouraged by the latest findings and went on to state that Cocrystal is going to continue with testing for antiviral activity against other variants of the virus as well. Investors could consider adding the Cocrystal stock to their watch lists at this point.

Technical Indicators

CCI20210.1682OverBoughtChaikin Money Flow0.1332Buy
MACD0.0051BuyMoney Flow Index80.3334OverBought
STOCH (14,3)85.2941OverBoughtSTOCH RSI1.0000OverBought
UO58.0938SellWilliams %R-14.7059OverBought

Pivot Points

NameS3S2S1Pivot PointsR1R2R3

Related Posts

About The Author